Organocatalytic asymmetric conjugate addition of 1,3-dicarbonyl compounds to maleimides
Organocatalytic asymmetric conjugate addition of 1,3-dicarbonyl compounds to maleimides
复制标题
DOI:
10.1002/anie.200600370
复制
发表时间:
2006-01-01
影响因子:
16.6
通讯作者:
Melchiorre, Paolo
中科院分区:
文献类型:
--
作者:
Bartoli, Giuseppe;Bosco, Marcella;Melchiorre, Paolo
of both enantio-(up to 98% ee) and diastereoselectivity (dr= up to> 98: 2) with both cyclic and acyclic β-ketoesters and with cyclic β-diketones. Furthermore, the strategy is based on an operationally simple procedure in which unmodified cheap and commercially available starting materials and catalysts are used.The asymmetric conjugate addition of carbon-centered nucleophiles to maleimides should provide a practical route to synthetically and biologically important chiral α-substituted succinimides.[10] Therefore, it is surprising that, to our knowledge, just one effective asymmetric strategy has been described to date.[11] The feasibility of our organocatalytic asymmetric approach was first tested by mixing methyl-2-oxo-1-indanecarboxylate (1a) and maleimide (2a) in dichloromethane (0.5 m) in the presence of a catalytic amount of a cinchona alkaloid derivative (10mol%); representative results of the extensive screen of reaction conditions using the alkaloids shown in Scheme 1 are listed in Table 1. The natural cinchona alkaloid quinine (Q) proved to be the most promising catalyst and afforded the 1, 4-adduct with relatively good diastereo-and enantioselectivity (Table 1, entry 2). The synthetic cinchona alkaloid derivatives A and B, which are broadly effective bifunctional organocatalysts for several asymmetric CÀC bond-forming reactions,[12] gave poor results (Table1, entries3 and 4). The rigid phenolic quinidine derivative β-isocupreidine (C; Scheme1)[13] promoted the conjugate addition with satisfactory selectivity (Table1, entry5), but the results obtained when the reaction was performed at À208C indicated a significant difference between Q and C in terms of catalytic activity (Table1, entries 6/7 and 8/9).